Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for neuroprotection

DSpace/Manakin Repository

Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for neuroprotection

Citable link to this page

 

 
Title: Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for neuroprotection
Author: Koutmani, Y; Politis, P K; Elkouris, M; Agrogiannis, G; Kemerli, M; Patsouris, E; Remboutsika, E; Karalis, K P

Note: Order does not necessarily reflect citation order of authors.

Citation: Koutmani, Y, P K Politis, M Elkouris, G Agrogiannis, M Kemerli, E Patsouris, E Remboutsika, and K P Karalis. 2013. Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for neuroprotection. Molecular Psychiatry 18(3): 300-307.
Full Text & Related Files:
Abstract: Neurogenesis during embryonic and adult life is tightly regulated by a network of transcriptional, growth and hormonal factors. Emerging evidence indicates that activation of the stress response, via the associated glucocorticoid increase, reduces neurogenesis and contributes to the development of adult diseases.As corticotrophin-releasing hormone (CRH) or factor is the major mediator of adaptive response to stressors, we sought to investigate its involvement in this process. Accordingly, we found that CRH could reverse the damaging effects of glucocorticoid on neural stem/progenitor cells (NS/PCs), while its genetic deficiency results in compromised proliferation and enhanced apoptosis during neurogenesis. Analyses in fetal and adult mouse brain revealed significant expression of CRH receptors in proliferating neuronal progenitors. Furthermore, by using primary cultures of NS/PCs, we characterized the molecular mechanisms and identified CRH receptor-1 as the receptor mediating the neuroprotective effects of CRH. Finally, we demonstrate the expression of CRH receptors in human fetal brain from early gestational age, in areas of active neuronal proliferation. These observations raise the intriguing possibility for CRH-mediated pharmacological applications in diseases characterized by altered neuronal homeostasis, including depression, dementia, neurodegenerative diseases, brain traumas and obesity.
Published Version: doi:10.1038/mp.2012.198
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578949/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10589792
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters